To do so, Rowan’s board of trustees will vote Feb. 17 on a feasibility study. The study — which, if approved, would be conducted by Pittsburgh-based consulting firm Tripp Umbach — will look at a potential partnership between Rowan University School of Osteopathic Medicine and Atlantic City-based AtlantiCare.
“We have discussed creating educational opportunities in Atlantic City with Rowan,” said an AtlantiCare spokeswoman via email, according to the report. “A feasibility study would be the next step in evaluating the viability of such a program.”
Ken Blank, Rowan University’s senior vice president for health sciences, voiced a similar opinion. “You don’t just go into an area, you really need to establish a relationship with a partner, somebody who has common goals, somebody who shares the issues surrounding medical education, and that’s what we’ve been talking to AtlantiCare about,” Mr. Blank said, according to the report.
More articles on medical schools:
Harvard Medical School professor named president of Wellesley College
Mercer University School of Medicine revamps its campus in Savannah
University of Nevada, Las Vegas School of Medicine moves closer to accreditation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.